Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Oportun Financial Corporation delivered solid financial results for Q2 2026, with GAAP net income rising 24% year-over-year to $8.5 million and adjusted EBITDA increasing 56% to $49 million. The company outperformed revenue and EBITDA guidance, improved its delinquency rate to the lowest since Q4 2021, and raised its full year adjusted EBITDA outlo…
Duolingo reported stronger-than-expected engagement metrics for the second quarter and raised its DAU growth outlook, but projected third-quarter revenue that fell short of analysts' estimates. Management said it is focusing on expanding daily active users rather than near-term monetization, a strategy that weighed on the stock after hours despite …
Honeywell Aerospace cut its 2026 organic sales-growth forecast and reduced its annual adjusted earnings-per-share outlook after supply-chain bottlenecks compelled the company to divert production toward aircraft OEMs and domestic defense programs, weighing on aftermarket margins and quarterly profitability.
Context Therapeutics reported its Q2 2026 financial results, highlighting progress in its T cell engaging bispecific antibody pipeline for solid tumors. The company presented encouraging interim Phase 1a data for CTIM-76 in platinum-resistant ovarian cancer and initiated a Phase 1 trial for CT-202 targeting multiple cancers. Cash reserves of $43 mi…
Chime boosted its 2026 revenue growth forecast and reported stronger-than-expected second-quarter results driven by higher payments and membership engagement, even as long-serving CFO Matt Newcomb prepares to leave and the company trims staff by 10%. The fintech’s active member base and average revenue per user both expanded, and the company posted…
Etsy Inc. plans to eliminate roughly 220 positions, representing about 12% of its workforce, primarily within product and engineering, as part of a restructuring disclosed in a U.S. Securities and Exchange Commission filing. The company's leadership framed the changes as a move to improve coordination and speed of decision-making rather than a cost…
The Pennant Group, Inc., a U.S.-based healthcare holding company specializing in home health, hospice, and senior living services, reported robust second quarter 2026 financial results. The company achieved GAAP diluted earnings per share of $0.25 and adjusted EPS of $0.36, with total revenue rising 35.8% year-over-year to $298 million. Both segmen…
BOA Acquisition Corp. II completed an initial public offering of 14,375,000 units at $10.00 per unit, generating $143.75 million in gross proceeds. The offering included the full exercise of the underwriters' over-allotment option. Units began trading on the Nasdaq Global Market under the ticker THEOU on Aug. 4, 2026, and the company said it will p…
LifeMD, a virtual primary care and pharmacy services provider, reported Q2 2026 revenue of $47.3 million within guidance and a sequential adjusted EBITDA loss improvement of 21%. The company highlighted successful transition to branded GLP-1 weight management therapies, growing subscribers to 356,000, including 108,000 in weight management programs…
Federal Reserve Governor Lisa Cook said she is prepared to raise the central bank's short-term interest rate target if inflation does not begin to moderate. Speaking in remarks prepared for an Anchorage luncheon, Cook emphasized that risks to the inflation side of the Fed's mandate are currently larger than risks to employment and stressed a commit…
EZCORP, a leading pawn transaction provider, announced a 44% increase in net income for Q3 fiscal 2026, with adjusted net income rising 52% year-over-year. Total revenues grew 35% to $418.7 million, supported by a 33% rise in pawn loans outstanding and strong performance in merchandise sales and jewelry scrap. The company expanded its store footpri…
Mueller Water Products announced its fiscal Q3 2026 results showing 4.1% increase in net sales to $395.9 million and strong profit growth with net income rising 28.2% to $67.3 million. Adjusted EBITDA increased 24.3% to $107.4 million and the company raised its full-year 2026 adjusted EBITDA guidance. Operational improvements, higher pricing, tarif…
Coca-Cola Consolidated, Inc. (NASDAQ: COKE), the largest Coca-Cola bottler in the U.S., reported its second quarter and first half 2026 financial results showing 11% net sales growth and operating income up 10.2% year-over-year for the first half. Volume grew 7.6% in Q2 driven by strong demand spurred by events like America250™ and the FIFA World C…
One Liberty Properties, Inc. (NYSE: OLP), a REIT specializing in industrial properties, announced robust second quarter 2026 results including net income of $0.71 per share, a 10.3% rental income increase year over year, and high portfolio occupancy of 97.6%. The company further strengthened its balance sheet by entering a new $100 million credit f…
SiTime Corporation announced impressive second quarter 2026 financial results with revenue surging 127% year-over-year to $157.4 million and strong gross margins of 67.1%. The company completed the acquisition of Renesas Electronics Corporation's Timing Business, significantly expanding its product portfolio. Non-GAAP net income was $65.6 million (…
Alto Ingredients, Inc. announced its second quarter 2026 financial results, showing a significant turnaround with net income of $11.4 million compared to a prior loss, and adjusted EBITDA of $23.7 million. The company's strategic diversification into renewable fuels, specialty alcohols, and essential ingredients has enabled consistent profitability…
Pacific Biosciences of California, Inc. announces the appointment of Mark Van Oene as President and CEO, succeeding Christian Henry. Van Oene has been COO since 2021 and has been integral in advancing the company's operational execution, commercial strategy, and AI-enabled product developments. The leadership change aims to continue the company's g…
Emergent BioSolutions highlights the increasing importance of preparedness against biological threats in light of evolving security challenges magnified by AI and synthetic biology. The company emphasizes cross-sector collaboration to advance safeguards and response capabilities, underscoring its role in providing vaccines like CYFENDUS® for post-e…
Emergent BioSolutions announced robust Q2 2026 revenues of $234.3 million, up 66% year-over-year, driven by increased biodefense contract modifications with the U.S. government. Despite this, the company reported a significant net loss of $180.2 million, primarily due to a $191.3 million non-cash impairment related to its naloxone asset group. Adju…
Tenaya Therapeutics announced positive interim Phase 1b/2 clinical trial results for gene therapies TN-201 and TN-401 treating hypertrophic cardiomyopathy (HCM) and arrhythmogenic right ventricular cardiomyopathy (ARVC), respectively. Both treatments showed meaningful clinical improvements and good tolerability. The company is progressing TN-301, a…
Great Elm Capital Corp. (GECC) announced its second quarter 2026 financial results, highlighting a 3% quarter-over-quarter NAV increase to $7.95 per share, $0.32 net investment income per share, and $1.9 million of net realized and unrealized gains. The company strengthened its capital structure by retiring expensive debt, extended its revolving cr…
Barrett Business Services, Inc. (NASDAQ: BBSI) reported Q2 2026 revenues increased 4% to $319.3 million with gross billings rising 3%. Despite revenue growth driven by new client additions and higher billings per employee, net income declined to $12.9 million ($0.52 per diluted share) compared to $18.5 million ($0.70 per diluted share) last year, m…
Crane NXT, Co. (NYSE: CXT) announced robust financial results for Q2 2026, including a 22% year-over-year increase in sales to $493 million and a 13% rise in adjusted earnings per share (EPS) to $1.10. The company raised its full-year adjusted EPS guidance to a range of $4.22 to $4.42, reflecting confidence in ongoing momentum and successful integr…
Vaxcyte reported its Q2 2026 financial results, highlighting progress in its VAX-31 pneumococcal conjugate vaccine Phase 3 program with topline data from the OPUS-1 trial expected by Q4 2026 and additional OPUS-2 and OPUS-3 results in H1 2027. The company is also advancing its early-stage pipeline including VAX-A1 for Group A Streptococcus in Phase…
ADMA Biologics delivered a strong second quarter in 2026 with total revenue up 2% year-over-year to $124.4 million, powered by a 24% increase in ASCENIV revenues. The company's flagship product, ASCENIV, showed accelerated demand and utilization, while BIVIGAM revenue stabilized after prior declines. GAAP net income grew 11% year-over-year to $37.8…
